Updates from ASH in Later Line Multiple Myeloma Management
ASH 2023 Insights: "KarMMa-2 Extended Follow-Up - Ide-Cel in Pts With High-Risk NDMM With Inadequate Response to Frontline AutoSCT"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Melissa Alsina
By
Insights from 2023 ASH Annual Meeting
FEATURING
Melissa Alsina
Login to view comments.
Click here to Login
